Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An experimental and computational study of graphene oxide functionalized with tris(hydroxymethyl)aminomethane as an electrode material for supercapacitors.

ABSTRACT: In this research, graphene oxide (GO) functionalized with tris(hydroxymethyl)aminomethane (T) was synthesized with a simple one-pot method, and applied as an electrode material for supercapacitors. Electrochemical measurements on the synthesized tris(hydroxymethyl)aminomethane-functionalized graphene oxide (GO@T) indicated a specific capacitance of 549.8 F g^- 1 at a specific current of 2.5 A g^- 1 and a specific capacitance of 358 F g^-1 at a specific current of 7 A g^- 1 in the potential range of - 0.5-0.5 V versus Ag/AgCl. It also showed a high cyclic stability. According to the results, 80 and 68% of the initial capacitance was retained after 5500 and 9300 cycles, respectively. Density functional theory calculations were used to investigate the quantum capacitance, free energy change during functionalization reaction, and the layer distance of GO and GO@T.

SUBMITTER: Mohammadi S

PROVIDER: S-EPMC10556013 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

An experimental and computational study of graphene oxide functionalized with tris(hydroxymethyl)aminomethane as an electrode material for supercapacitors.

Mohammadi Samira S Mousavi-Khoshdel S Morteza SM

Scientific reports 20231005 1

In this research, graphene oxide (GO) functionalized with tris(hydroxymethyl)aminomethane (T) was synthesized with a simple one-pot method, and applied as an electrode material for supercapacitors. Electrochemical measurements on the synthesized tris(hydroxymethyl)aminomethane-functionalized graphene oxide (GO@T) indicated a specific capacitance of 549.8 F g- 1 at a specific current of 2.5 A g- 1 and a specific capacitance of 358 F g-1 at a specific current of 7 ...[more]

PMID: 37798403

Similar Datasets

Intrinsic Buffer Hydroxyl Radical Dosimetry Using Tris(hydroxymethyl)aminomethane.

Project description:Fast photochemical oxidation of proteins (FPOP) is a powerful covalent labeling tool that uses hydroxyl radicals generated by laser flash photolysis of hydrogen peroxide to footprint protein surfaces. Because radical production varies with many experimental parameters, hydroxyl radical dosimeters have been introduced to track the effective radical dosage experienced by the protein analyte. FPOP experiments performed using adenine optical radical dosimetry containing protein in Tris buffer demonstrated unusual dosimetry behavior. We have investigated the behavior of Tris under oxidative conditions in detail. We find that Tris can act as a novel gain-of-signal optical hydroxyl radical dosimeter in FPOP experiments. This new dosimeter is also amenable to inline real-time monitoring, thereby allowing real-time adjustments to compensate for differences in samples for their quenching ability.

| S-EPMC7650270 | biostudies-literature

Diaminopyrene modified reduced graphene oxide as a novel electrode material for excellent performance supercapacitors.

Project description:In this paper, novel reduced graphene oxide (rGO) composites (DAPrGOs) modified by diaminopyrene (DAP) were successfully synthesized via a facile solvothermal reaction method and used for supercapacitors. Compared with the pristine rGO, the DAPrGO1 electrode showed distinctly better performance (397.63 F g-1 vs. 80.29 F g-1 of pristine rGO at 0.5 A g-1) with small charge transfer resistance. When a symmetric device was fabricated using DAPrGO1 as the active material, it also exhibited a high capacitance of 82.70 F g-1 at 0.5 A g-1 with an energy density of 25.84 W h kg-1 at a power density of 375 W kg-1, and even offered a high power density of 7500 W kg-1 (18.71 W h kg-1) at 10 A g-1. Moreover, the device possessed good electrochemical stability up to 20 000 cycles, implying promising applications in energy storage fields.

| S-EPMC9047509 | biostudies-literature

Crystal structure of Sphingobacterium multivorum serine palmitoyltransferase complexed with tris(hydroxymethyl)aminomethane.

Project description:Serine palmitoyltransferase (SPT) catalyses the first reaction in sphingolipid biosynthesis: the decarboxylative condensation of L-serine (L-Ser) and palmitoyl-CoA to form 3-ketodihydrosphingosine. SPT from Sphingobacterium multivorum has been isolated and its crystal structure in complex with L-Ser has been determined at 2.3 Å resolution (PDB entry 3a2b). However, the quality of the crystal was not good enough to judge the conformation of the cofactor molecule and the orientations of the side chains of the amino-acid residues in the enzyme active site. The crystal quality was improved by revision of the purification procedure and by optimization of both the crystallization procedure and the post-crystallization treatment conditions. Here, the crystal structure of SPT complexed with tris(hydroxymethyl)aminomethane (Tris), a buffer component, was determined at 1.65 Å resolution. The protein crystallized at 20°C and diffraction data were collected from the crystals to a resolution of 1.65 Å. The crystal belonged to the tetragonal space group P41212, with unit-cell parameters a = b = 61.32, c = 208.57 Å. Analysis of the crystal structure revealed C4-C5-C5A-O4P (77°) and C5-C5A-O4P-P (-143°) torsion angles in the phosphate-group moiety of the cofactor pyridoxal 5'-phosphate (PLP) that are more reasonable than those observed in the previously reported crystal structure (14° and 151°, respectively). Furthermore, the clear electron density showing a Schiff-base linkage between PLP and the bulky artificial ligand Tris indicated exceptional flexibility of the active-site cavity of this enzyme. These findings open up the possibility for further study of the detailed mechanisms of substrate recognition and catalysis by this enzyme.

| S-EPMC9716569 | biostudies-literature

Tris(hydroxymethyl)aminomethane induces conformational change and crystal-packing contraction of porcine pancreatic elastase.

Project description:Porcine pancreatic elastase (PPE) was crystallized under new sulfate-free conditions containing 0.3 M NaCl and 50 mM tris(hydroxymethyl)aminomethane-HCl at pH 7.0. The crystal structure determined at 1.5 angstroms resolution had a unique conformation in four regions which contained loop portions. A chloride ion was bound near the catalytic triad instead of the sulfate ion in PDB entry 1qnj, a typical PPE crystal structure. However, the chloride ion did not affect the configuration of the catalytic triad. A tris(hydroxymethyl)aminomethane (Tris) molecule was bound to the S4 and S5 subsites in place of the adjacent molecule in the 1qnj crystal and played a significant role in the structural change of the region. The distortion in this region may subsequently have induced conformational changes in the other three regions. The fact that Tris and these four regions make a diagonal line in the ac plane may have affected the crystal-packing contraction along the a and c axes in the crystal compared with the typical crystal.

| S-EPMC2242949 | biostudies-literature

Tris(hydroxymethyl)aminomethane Linker-Bearing Triazine-Based Triglucosides for Solubilization and Stabilization of Membrane Proteins.

Project description:High-resolution membrane protein structures are essential for a fundamental understanding of the molecular basis of diverse cellular processes and for drug discovery. Detergents are widely used to extract membrane-spanning proteins from membranes and maintain them in a functional state for downstream characterization. Due to limited long-term stability of membrane proteins encapsulated in conventional detergents, development of novel agents is required to facilitate membrane protein structural study. In the current study, we designed and synthesized tris(hydroxymethyl)aminomethane linker-bearing triazine-based triglucosides (TTGs) for solubilization and stabilization of membrane proteins. When these glucoside detergents were evaluated for four membrane proteins including two G protein-coupled receptors, a few TTGs including TTG-C10 and TTG-C11 displayed markedly enhanced behaviors toward membrane protein stability relative to two maltoside detergents [DDM (n-dodecyl-β-d-maltoside) and LMNG (lauryl maltose neopentyl glycol)]. This is a notable feature of the TTGs as glucoside detergents tend to be inferior to maltoside detergents at stabilizing membrane proteins. The favorable behavior of the TTGs for membrane protein stability is likely due to the high hydrophobicity of the lipophilic groups, an optimal range of hydrophilic-lipophilic balance, and the absence of cis-trans isomerism.

| S-EPMC10145683 | biostudies-literature

Solution-processed graphene oxide electrode for supercapacitors fabricated using low temperature thermal reduction.

Project description:We present a low temperature and solution-based fabrication process for reduced graphene oxide (rGO) electrodes for electric double layer capacitors (EDLCs). Through the heat treatment at 180 °C between the spin coatings of graphene oxide (GO) solution, an electrode with loosely stacked GO sheets could be obtained, and the GO base coating was partially reduced. The thickness of the electrodes could be freely controlled as these electrodes were prepared without an additive as a spacer. The GO coating layers were then fully reduced to rGO at a relatively low temperature of 300 °C under ambient atmospheric conditions, not in any chemically reducing environment. Raman spectroscopy and X-ray photoelectron spectroscopy (XPS) results showed that the changes in oxygen functional groups of GO occurred through the heat treatments at 180 and 300 °C, which clearly confirmed the reduction from GO to rGO in the proposed fabrication process at the low thermal reduction temperatures. The structural changes before and after the thermal reduction of GO to rGO analyzed using Molecular Dynamic (MD) simulation showed the same trends as those characterized using Raman spectroscopy and XPS. An EDLC composed of the low temperature reduced rGO-based electrodes and poly(vinyl alcohol)/phosphoric acid (PVA/H3PO4) electrolyte gel was shown to have high specific capacitance of about 240 F g-1 together with excellent energy and power densities of about 33.3 W h kg-1 and 833.3 W kg-1, respectively. Furthermore, a series of multiple rGO-based EDLCs was shown to have fast charging and slow discharging properties that allowed them to light up a white light emitting diode (LED) for 30 min.

| S-EPMC9054540 | biostudies-literature

Improved Biocompatibility of Amino-functionalized Graphene Oxide in Caenorhabditis elegans

Project description:Graphene oxide (GO) holds high promise for diagnostic and therapeutic applications in nanomedicine but reportedly displays immunotoxicity, underlining the need for developing functionalized GO with improved biocompatibility. Here, we study the adverse effects of GO and amino-functionalized GO (GONH2) during Caenorhabditis elegans development and ageing upon acute or chronic exposure. Chronic GO treatment throughout the C. elegans development causes decreased fecundity and a reduction of animal size, while acute treatment does not lead to any measurable physiological decline. However, RNA-Seq data reveal that acute GO exposure induces innate immune gene expression. The p38 MAP kinase, PMK-1, which is a well-established master regulator of innate immunity, protects C. elegans from chronic GO toxicity, as pmk-1 mutants show reduced tissue-functionality and facultative vivipary. In a direct comparison, GONH2 exposure does not cause detrimental effects in the wild type or in pmk-1 mutants, and the innate immune response is considerably less pronounced. Our work establishes the enhanced biocompatibility of amino-functionalized GO in a whole-organism, emphasizing its potential as biomedical nanomaterial.

2022-05-10 | GSE131070 | GEO

Enhancement of The Stability of Human Growth Hormone by Using Tris(hydroxymethyl)aminomethane: Molecular Docking and Experimental Analysis.

Project description:ObjectiveIt is so difficult to formulate human growth hormone (hGH) in a solution with high stability and new drug delivery system (NDDs) due to physiochemical instability. The purpose of this study was to investigate the possibility of using Tris as a hGH stabilizer.Materials and methodsIn this experimental study, the role of tris(hydroxymethyl)aminomethane (Tris) was evaluated as a hGH stabilizing agent in phosphate buffer, as a practical aqueous solution and a media to release NDDs. Highperformance liquid chromatography (HPLC) and enzyme-linked immune sorbent assay (ELISA) were applied to investigate the stability of hGH in solutions and dynamic light scattering (DLS) was used to measure the effect of Tris on the hydrodynamic size of hGH in aqueous solutions. Ultra violet (UV) spectrophotometry was used to check the hGH spectrum. In computational study, formation of ligand-protein complex of the Tris-hGH, and the intermolecular interactions between Tris and hGH were studied by molecular docking modeling.ResultsThe results demonstrated that Tris at the optimum concentration, increases hGH stability in aqueous solutions. Also, molecular docking modeling confirmed that amino acid residues such as tyrosine (Tyr), proline (Pro), glutamic acid (Glu), aspartic acid (Asp), leucine (Leu), and phenylalanine (Phe) in hGH structure, were linked with Tris as a ligand.ConclusionIt seems that interactions between hGH and Tris are the most important reason for increment of the physicochemical stability of hGH in aqueous solutions containing Tris.

| S-EPMC7211290 | biostudies-literature

Microwave synthesis of antimony oxide graphene nanoparticles – a new electrode material for supercapacitors† † Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3na00514c

Project description: Not available

| S-EPMC10496916 | biostudies-literature

Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry.

Project description:A novel COVID-19 vaccine (BriLife®) has been developed by the Israel Institute for Biological Research (IIBR) to prevent the spread of the SARS-CoV-2 virus throughout the population in Israel. One of the components in the vaccine formulation is tris(hydroxymethyl)aminomethane (tromethamine, TRIS), a buffering agent. TRIS is a commonly used excipient in various approved parenteral medicinal products, including the mRNA COVID-19 vaccines produced by Pfizer/BioNtech and Moderna. TRIS is a hydrophilic basic compound that does not contain any chromophores/fluorophores and hence cannot be retained and detected by reverse-phase liquid chromatography (RPLC)-ultraviolet (UV)/fluorescence methods. Among the few extant methods for TRIS determination, all exhibit a lack of selectivity and/or sensitivity and require laborious sample treatment. In this study, LC-mass spectrometry (MS) with its inherent selectivity and sensitivity in the multiple reaction monitoring (MRM) mode was utilized, for the first time, as an alternative method for TRIS quantitation. Extensive validation of the developed method demonstrated suitable specificity, linearity, precision, accuracy and robustness over the investigated concentration range (1.2-4.8 mg/mL). Specifically, the R2 of the standard curve was >0.999, the recovery was >92%, and the coefficient of variance (%CV) was <12% and <6% for repeatability and intermediate precision, respectively. Moreover, the method was validated in accordance with strict Good Manufacturing Practice (GMP) guidelines. The developed method provides valuable tools that pharmaceutical companies can use for TRIS quantitation in vaccines and other pharmaceutical products.

| S-EPMC9822354 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data